Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment

PURPOSE: With the advance of screening techniques, there is a growing number of low-risk or intermediate-risk prostate cancer (PCa) cases, remaining a serious threat to men’s health. To obtain better efficacy, a growing interest has been attracted to develop such emerging treatments as immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wenfeng, Li, Chaoming, Xu, Naijin, Watanabe, Masami, Xue, Ruizhi, Xu, Abai, Araki, Motoo, Sun, Ruifen, Liu, Chunxiao, Nasu, Yasutomo, Huang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052122/
https://www.ncbi.nlm.nih.gov/pubmed/33880023
http://dx.doi.org/10.2147/IJN.S301552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052122/
https://www.ncbi.nlm.nih.gov/pubmed/33880023
http://dx.doi.org/10.2147/IJN.S301552

Ejemplares similares